News
Clinical trial market report for Serbia
The number of clinical trials starting in Serbia is returning to pre-pandemic levels, but the context in which these studies are operating has changed. The impact of COVID-19 demonstrated the limitations of the direct-to-site logistics model, when supply chains were...
The logistics of extending the footprint of advanced therapy trials
Cell and gene therapy innovators are scaling up and out to reach more patients. Clinical Trials Arena spoke to the team at Oximio (formerly the SMO Group) to discuss market developments. Most advanced therapy medicinal products (ATMPs, also known as cell and gene...
Global HR Digitalization at Oximio
Over the past two years, Oximio’s operations have been affected by a combination of two factors: organic growth and geographic expansion. Significant organizational expansion has necessitated a comprehensive reconstruction of the human resources area – as...
Design for life: How to optimise costs and innovation in clinical trials using global sourcing strategies
No one has ever said that running clinical trials is easy. Rather, studies are arguably increasing in complexity due to ever-more sophisticated treatments, globalisation and the sharp rise in trends such as the boom in direct-to-patient (DtP) services. Meanwhile,...
Seven trends and market changes affecting clinical trials in 2021
The last 12 months were full of challenges for trial sponsors and the clinical trials market saw dynamic change when the Covid-19 pandemic introduced new logistical problems that had to be confronted and solved rapidly. Now, as the dust begins to settle,...
Oximio’s breath of fresh air
Transformation is an overused word in the modern business lexicon, so it’s refreshing to hear a business leader, in the midst of what many would consider a legitimate excuse to use the T word, talk instead about continuity and stability....
Oximio announces new Chief Operating Officer
HUNTINGDON, Cambridgeshire, United Kingdom – 23 March 2021 – Clinical trial services provider, Oximio announced today that Peter Szabados has been appointed as the Chief Operating Officer (COO), joining the leadership team to enhance the client-focused operation....
Press Release: The SMO Group announces company name change to Oximio
HUNTINGDON, Cambridgeshire, United Kingdom - 1 March 2021 – The global clinical trial services provider The SMO Group has announced today that the company will begin operating under a new name and will be known henceforth as Oximio, effective immediately. The 18...
Opening of new warehouses in Serbia and Hungary
The decision to open our own depots in Hungary and Serbia was brought about by measuring the efficiency of the investment, in parallel with a thorough risk analysis. Opening our own depots in the CEE and SEE regions are a clear and logical step for our location...
Registered office address change – UK
As of the 4th of December 2020, SMO UK Limited, and SP-Logistics Holdings Ltd has a new Registered office address from which it will operate and receive post. Our new Registered office address is the following: Gibson House, Ermine Business Park,...